Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
February 14, 2019
Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia
February 13, 2019
5AM Ventures Closes Two Life Science Venture Capital Funds
January 31, 2019
Audentes Therapeutics Announces Next Steps in the Development of AT132 to Treat XLMTM Following Collaborative Initial Meeting with FDA Under RMAT Designation
January 31, 2019
Kinestral Technologies Secures Over $100 Million in Series D Funding Led by SK Holdings
January 7, 2019
Homology Medicines Achieves 2018 Goals and Prepares PKU Gene Therapy Program for the Clinic with Initial Data Expected in 2019
January 7, 2019
Audentes Therapeutics Reports on Recent Progress and Outlines 2019 Key Priorities
January 6, 2019
Impel Neuropharma Announces Positive Phase 1 Trial For INP105 For The Treatment Of Acute Agitation In Bipolar I Disorder And Schizophrenia
January 4, 2019
Arvinas Receives Authorization To Proceed For Its IND Application For PROTAC™ Therapy
January 4, 2019
Pear Therapeutics Completes $64M Series C Financing
January 3, 2019
Cabaletta Bio Closes $50 Million Series B Financing to Establish Translational Research and Advanced Manufacturing Capabilities for Chimeric AutoAntibody Receptor (CAAR) T Cell Products to Treat B Cell-Mediated Autoimmune Diseases
« Previous Page
1
…
9
10
11
12
Next Page »